GENESEN
Genesen is developing peptide-based new drugs that provides the treatment of autoimmune and inflammatory diseases.
GENESEN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.genesenbio.com
Total Employee:
11+
Status:
Active
Contact:
02-569-3738
Total Funding:
1.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro Google Maps ASP.NET IIS Pound Sterling IIS 10
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Current Employees Featured
Seongho Lee President and CEO @ Genesen
President and CEO
More informations about "Genesen"
Genesen - Crunchbase Company Profile & Funding
Organization. Genesen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@genesenbio.com; Phone Number …See details»
Genesen Company Profile 2024: Valuation, Funding & Investors
Genesen General Information Description. Developer of peptide drug designed for the treatment of autoimmune and inflammatory diseases. The company specializes in biopharmaceutical …See details»
Genesen Company Profile - Office Locations, Competitors ... - Craft
Genesen has 5 employees at their 1 location and $1.9 m in total funding,. See insights on Genesen including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Genesen - Products, Competitors, Financials, Employees, …
Genesenbio.com. Overview & Products; Financials; People; Founded Year 2018. Stage Seed VC | Alive. Total Raised $1.89M. Last Raised $1.89M | 5 yrs ago. About Genesen. Genesen is a …See details»
Genesen - Company Profile - Tracxn
Genesen ranks 182nd among 242 active competitors. 93 of its competitors are funded while 51 have exited. Overall, Genesen and its competitors have raised over $12.7B in funding across …See details»
Genesen Co. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Genesen Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Genesen - Overview, News & Competitors | ZoomInfo.com
View Genesen (www.genesenbio.com) location in Provence-Alpes-Cote d'Azur, France , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Genesen - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 8, 2020:See details»
Genesen - LinkedIn
Genesen | 36 followers on LinkedIn. ... العربية (Arabic) বাংলা (Bangla) Čeština (Czech)See details»
Genesen - Contacts, Employees, Board Members, Advisors & Alumni
Genesen is developing peptide-based new drugs that provides the treatment of autoimmune and inflammatory diseases.See details»
Sung Ho Lee - CEO - Genesen Co.,LTD (주)젠센 | LinkedIn
Genesen ltd (주)젠센 CEO · Majored in Protein Biochemistry<br><br>Eyegen Inc. R&D Department, Senior Scientist, Director 2000-2004<br> - Development of disease treatment …See details»
Genesen - Company Information, Competitors, News & FAQs
Find useful insights on Genesen's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Genesen.See details»
Genesen Inc. - Pharmaceuticals - Genesen Inc. - LinkedIn
The therapeutics effect of GSP-1 is proved by in vitro and in vivo experiments, and the pre-clinical development, ADME study, collaboration with our partners are planned to prepare IND …See details»
Genesen secures $1.9M for peptide-based autoimmune disease
Jan 14, 2020 HONG KONG – South Korean biopharma Genesen Inc. has secured ₩2.2 billion (US$1.9 million) in seed funding to advance its peptide-based drug candidates for the …See details»
스타트업DB 젠센 | 한국경제 - 한경닷컴
스타트업DB 젠센, 한경 긱스는 혁신에 몰입하고 미래를 바꾸는 다양한 긱(괴짜)들의 이야기를 다룹니다.See details»
젠센(자가면역질환 치료제) - 기업정보 | 투자, 매출, 기업가치 - THE VC
주식회사 젠센(genesen)은 2018년 7월에 설립된 한국계∙스타트업입니다. 바이오/의료∙면역질환 분야의 자가면역질환 치료제가 주요 제품/서비스입니다. 본사는 한국∙서울특별시에 …See details»
Core Values - Genezen
Our values are a part of our DNA. Genezen was founded to serve as a trusted partner between therapeutic companies and academic vector cores. Throughout our remarkable evolution, we …See details»
Genezen - Crunchbase Company Profile & Funding
Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.See details»
With new facility and leadership, CDMO Genezen is stepping up to …
Sep 17, 2021 Construction is underway on the 75,000-square-foot lentiviral and retroviral vector production facility. Genezen expects the site to come online in the first half of 2022, after …See details»
Biogen Canada’s Marina Vasiliou: A 100% Commitment to …
Jul 11, 2019 Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of geographies.See details»